What is Circadiance?
Circadiance operates at the intersection of medical technology and respiratory health, providing a sophisticated suite of remote patient monitoring products. The company specializes in cloud-based platforms that facilitate seamless data transmission between healthcare professionals and their patients. Their product portfolio, which includes specialized PAP devices for sleep-disordered breathing and non-invasive ventilation systems for NICU patients, is engineered to optimize clinical workflows. By focusing on premature infant care and chronic respiratory conditions, Circadiance delivers measurable value to hospitals and homecare providers, effectively reducing hospital readmission rates while enhancing the quality of life for patients globally. The firm's emphasis on scalable, cloud-integrated hardware positions it as a critical player in the evolving landscape of telehealth and remote diagnostics.
How much funding has Circadiance raised?
Circadiance has raised a total of $915K across 2 funding rounds:
Debt
$765K
Debt
$150K
Debt (2015): $765K, investors not publicly disclosed
Debt (2020): $150K led by PPP
Key Investors in Circadiance
Undisclosed Investor
An institutional partner providing capital support for the company's initial debt-based growth phase.
PPP
Public-Private Partnership
What's next for Circadiance?
With the infusion of $150K, Circadiance is poised to enter a new phase of enterprise-level expansion. The strategic roadmap likely involves deepening the integration of its cloud-based monitoring ecosystem and expanding its footprint within global healthcare institutions. As the demand for remote patient management continues to surge, the company is expected to leverage this capital to enhance its R&D capabilities, potentially introducing next-generation ventilation technologies. By prioritizing operational efficiency and clinical efficacy, Circadiance aims to solidify its status as a leader in the respiratory care sector, ensuring that its technological advancements remain at the forefront of patient-centric innovation.
See full Circadiance company page
